Cashu
Inovio Pharmaceuticals Faces Class Action for Alleged Misleading Statements on Manufacturing Capabilities
2 days ago
Stocks
Health Care
ino
Inovio Pharmaceuticals
NASDAQ: INO
-0.00 (-0.29%)
1.735
USD
At close at Apr 01, 17:36 UTC
Overview
Loading chart...
Key Stats
Market Cap
93.21M
Dividend Yield
0.00%
P/E Ratio
-1.10
EPS
-3.99
Revenue
217.76K
Avg. Volume
880.31K
About
What does INO do?
Inovio Pharmaceuticals, based in San Diego, develops DNA medicines targeting infectious diseases, cancer, and HPV-related conditions, with key candidates including INO-3107 for recurrent respiratory papillomatosis. The company employs 122 people and utilizes CELLECTRA devices for DNA delivery.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.